Kevin J. Selva

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

Adam K. Wheatley, Jennifer A. Juno, Jing Jing Wang et al. · Nature Communications · 2021 · 400 citations · Full text

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine

Yi Ju, Wen Shi Lee, Emily H. Pilkington et al. · ACS Nano · 2022 · 294 citations

Systems serology detects functionally distinct coronavirus antibody features in children and elderly

Kevin J. Selva, Carolien E. van de Sandt, Melissa M. Lemke et al. · Nature Communications · 2021 · 172 citations · Full text

Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19

Shidan Tosif, Melanie R. Neeland, Philip Sutton et al. · Nature Communications · 2020 · 128 citations · Full text

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

Keith J. Chappell, Francesca L. Mordant, Zheyi Li et al. · The Lancet Infectious Diseases · 2021 · 117 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +4